Healthcare -
Biotechnology - NASDAQ - US
$ 4.62
0.217 %
$ 284 M
Market Cap
38.5
P/E
GLUE - NET INCOME
Net Income GLUE - Monte Rosa Therapeutics, Inc.
-72.7 M
LAST VALUE
18.14%
2 YEAR CAGR
-56.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR